June Sherie Almenoff Brainstorm Cell Therapeutics Inc. (BCLI) insider trading activity

BCLI Quotes by TradingView

June Sherie Almenoff is Director of BRAINSTORM CELL THERAPEUTICS INC.. Currently has a direct ownership of 6,000 shares of BCLI, which is worth approximately $11,580. The most recent transaction as insider was on Dec 15, 2021, when has been sold 2,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6K
0% 3M change
0% 12M change
Total Value Held $11,580

June Sherie Almenoff Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 15 2021
BUY
Grant, award, or other acquisition
-
2,000 Added 25.0%
6,000 Common Stock
Dec 10 2021
BUY
Grant, award, or other acquisition
-
2,000 Added 33.33%
4,000 Common Stock

Also insider at

TENX
TENAX THERAPEUTICS, INC. Healthcare
AVTX
Avalo Therapeutics, Inc. Healthcare
Director
JSA

June Sherie Almenoff

Director
Morrisville, NC

Track Institutional and Insider Activities on BCLI

Follow BRAINSTORM CELL THERAPEUTICS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCLI shares.

Notify only if

Insider Trading

Get notified when an Brainstorm Cell Therapeutics Inc. insider buys or sells BCLI shares.

Notify only if

News

Receive news related to BRAINSTORM CELL THERAPEUTICS INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BCLI